Column Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Column Capital Advisors's LLY Position: Q3 2023 in Review
Column Capital Advisors reduced its Eli Lilly (LLY) stake by 0.51% in Q3 2023, selling an estimated $2.07M and leaving 783,826 shares worth $14.4M. The position accounts for 2.12% of the portfolio, ranked #13.
Column Capital Advisors first reported a position in LLY in Q4 2019 and has held it in 16 quarters since. The position peaked at $14.6M in Q2 2023. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Column Capital Advisors held 783,826 shares of Eli Lilly worth $14.4M as of Q3 2023.
- Column Capital Advisors sold 4,010 Eli Lilly shares in Q3 2023, an estimated $2.07M.
- Eli Lilly made up 2.12% of Column Capital Advisors's portfolio in Q3 2023, its #13 holding.
- Column Capital Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 16 quarters since.
- Column Capital Advisors's Eli Lilly position peaked at $14.6M in Q2 2023.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.